梁倩欣, 董家铭, 谢曼琳, 邹艳芳, 涂兴明, & 赵可伟. (2022). 骨康方君臣佐使药治疗骨质疏松药理机制探讨. 中国骨质疏松杂志, 28(3), 440-445. https://doi.org/10.3969/j.issn.1006-7108.2022.03.024
Chicago Style (17th ed.) Citation梁倩欣, 董家铭, 谢曼琳, 邹艳芳, 涂兴明, and 赵可伟. "骨康方君臣佐使药治疗骨质疏松药理机制探讨." 中国骨质疏松杂志 28, no. 3 (2022): 440-445. https://doi.org/10.3969/j.issn.1006-7108.2022.03.024.
MLA (9th ed.) Citation梁倩欣, et al. "骨康方君臣佐使药治疗骨质疏松药理机制探讨." 中国骨质疏松杂志, vol. 28, no. 3, 2022, pp. 440-445, https://doi.org/10.3969/j.issn.1006-7108.2022.03.024.
Warning: These citations may not always be 100% accurate.